Atyr Pharma Inc (ATYR)

Stock price, financials, and technical signals for Atyr Pharma Inc (ATYR).

$3.60

-0.11

(-2.96%)

As of 02/12/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

ATYR Performance Snapshot


1-Week Chg

-8.63%

1-Month Chg

1.98%

3-Month Chg

3.15%

6-Month Chg

98.90%

1-Year Chg

82.74%

Year-To-Date Chg

-7.93%

Beta 1-Year

1.17

Beta 5-Year

0.85

Volatility (10-Day)

3.11%

ATYR Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-12

$3.60

-$0.11 (-2.96%)

$3.67

$3.81

$3.60

$3.67

1.32M ($4.77M)

2025-02-11

$3.71

-$0.06 (-1.59%)

$3.75

$3.75

$3.60

$3.69

511.55K ($1.90M)

2025-02-10

$3.77

-$0.13 (-3.33%)

$3.93

$3.93

$3.69

$3.80

638.33K ($2.41M)

2025-02-07

$3.90

$0.03 (0.78%)

$3.86

$3.98

$3.78

$3.88

748.38K ($2.92M)

2025-02-06

$3.87

-$0.07 (-1.78%)

$3.95

$3.99

$3.84

$3.90

586.19K ($2.27M)

2025-02-05

$3.94

$0.13 (3.41%)

$3.81

$3.96

$3.73

$3.88

774.10K ($3.05M)

2025-02-04

$3.81

$0.24 (6.72%)

$3.61

$3.87

$3.57

$3.75

878.79K ($3.35M)

2025-02-03

$3.57

-$0.29 (-7.51%)

$3.50

$3.60

$3.33

$3.50

1.30M ($4.64M)

2025-01-31

$3.86

$0.12 (3.21%)

$3.75

$3.95

$3.75

$3.85

692.10K ($2.67M)

2025-01-30

$3.74

$0.11 (3.03%)

$3.66

$3.83

$3.63

$3.73

571.63K ($2.14M)

ATYR Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $14.38M

    8.66%

  • Total assets

    $91.62M

    -26.75%

  • Total liabilities

    $26.48M

    -1.45%

  • Total investments

    $54.53M

    -40.95%

  • Shareholders' equity

    $65.33M

    -33.61%

  • Book value per share

    $0.86

    -49.29%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    -100.00%

  • Net income

    -$17.26M

    -52.20%

  • Operating expense

    $18.14M

    39.91%

  • Gross profit

    $0

    -100.00%

  • EBITDA

    -$16.87M

    -63.05%

  • Earnings per share

    -$0.23

    -15.00%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    $4.68M

    287.77%

  • Cash from operations

    -$13.16M

    -37.65%

  • Cash from investing

    $17.95M

    309.45%

  • Cash from financing

    -$105.00K

    -103.91%

  • Free cash flow

    -$13.17M

    -30.22%

  • Free cash flow per share

    -$0.17

    0.57%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $133.40M

    48.01%

  • Enterprise value

    $137.55M

    53.19%

  • Shares outstanding

    75.80M

    32.87%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    5.41

    -35.10%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.